Skip to main content

Reunion Neuroscience

Toronto, Canada

Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.

$68.9M raised
May 2025
Venture - Series Unknown

Top Investors

Novo HoldingsMPM CapitalPalo Santo FundFemHealth VenturesMitsui Global Investment

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Reunion Neuroscience

How much funding has Reunion Neuroscience raised?
Reunion Neuroscience has raised $68.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.
Who are Reunion Neuroscience's investors?
Reunion Neuroscience's investors include Novo Holdings, MPM Capital, Palo Santo Fund, FemHealth Ventures, Mitsui Global Investment.
Where is Reunion Neuroscience headquartered?
Reunion Neuroscience is headquartered in Toronto, Canada.
What does Reunion Neuroscience do?
Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.
What stage is Reunion Neuroscience at?
Reunion Neuroscience is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Reunion Neuroscience — Funding & Investors." VCBacked, May 5, 2025, https://www.vcbacked.co/company/reunion-neuroscience. Accessed June 4, 2026.
APA
VCBacked. (2025). Reunion Neuroscience — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/reunion-neuroscience
Wikipedia (cite web)
{{cite web |title=Reunion Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/reunion-neuroscience |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .